Page last updated: 2024-09-04

rp 73401 and Dermatitis, Atopic

rp 73401 has been researched along with Dermatitis, Atopic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, C; Engell, K; Felding, J; Hegardt, P; Ladefoged, LG; Larsen, J; Nielsen, SF; Poulsen, TD; Refer, P; Søhoel, A; Sørensen, MD; Thormann, T; Vinggaard, AM	1

Reviews

1 review(s) available for rp 73401 and Dermatitis, Atopic

Article	Year
Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis. Journal of medicinal chemistry, 2014, Jul-24, Volume: 57, Issue:14 Topics: Acetamides; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase 4 Inhibitors; Pyridines; Structure-Activity Relationship	2014

Article

Year

Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis.

Journal of medicinal chemistry, 2014, Jul-24, Volume: 57, Issue:14

Topics: Acetamides; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase 4 Inhibitors; Pyridines; Structure-Activity Relationship

2014